Aging population, healthcare costs and generics the backdrop as Japanese pharma comes in focus

When one of the year’s major events in Japanese pharma returns next month, the issues of an aging population, growing healthcare costs and the government’s attempts to address them are certain to crop up.

Japan is the world’s third largest pharma market with a value that is forecast to reach $115 billion by 2024, but legislative change is taking place as the government seeks to cut healthcare expenditure.

"Pharma manufacturers from places like India, but also Europe and the USA, will cement a foothold in Japanese pharma, as consumers here are highly brand-oriented"